Volume 21, Number 10—October 2015
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA
|Enterobacteriaceae (e.g., Escherichia coli, Klebsiella spp., Enterobacter spp., Proteus spp., Citrobacter spp. Serratia spp., Morganella spp., or Providentia spp.) with 1 of the following laboratory results:|
|1. Molecular test (e.g., PCR) specific for carbapenemase.|
|2. Phenotypic test (e.g., modified Hodge) specific for carbapenemase production.|
|3. For E. coli and Klebsiella spp. only: nonsusceptible (intermediate or resistant) to 1 of the following carbapenems (doripenem, meropenem, or imipenem) AND resistant to ALL of the following third-generation cephalosporins tested (ceftriaxone, cefotaxime, and ceftazidime). Note: ignore ertapenem for this definition.|
*As of November 1, 2013. CRE, carbapenem-resistant Enterobacteriaceae; XDRO, extensively drug-resistant organism.
Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.